Macular Degeneration Treatment Global Market Report 2025

Macular Degeneration Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on macular degeneration treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for macular degeneration treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The macular degeneration treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Stage of Disease: Early-Stage AMD; Intermediate AMD; Late-Stage AMD

2) By End User: Ambulatory Surgical Centers; Ophthalmic Clinics; Hospitals

3) By Route of Administration: Oral; Injectable; Other Route of Administration

4) By Types: Wet Macular Degeneration, Dry Macular Degeneration

Subsegments:

1) By Early-Stage AMD: Nutritional Supplements; Lifestyle Modification Treatments

2) By Intermediate AMD: Anti-VEGF Injections; Photodynamic Therapy

3) By Late-Stage AMD: Surgical Treatments; Advanced Anti-VEGF Therapies; Gene Therapy Options

Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Allergan Inc.; Bayer AG; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.


1. Executive Summary
2. Macular Degeneration Treatment Market Characteristics
3. Macular Degeneration Treatment Market Trends And Strategies
4. Macular Degeneration Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Macular Degeneration Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Macular Degeneration Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Macular Degeneration Treatment Market Growth Rate Analysis
5.4. Global Macular Degeneration Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Macular Degeneration Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Macular Degeneration Treatment Total Addressable Market (TAM)
6. Macular Degeneration Treatment Market Segmentation
6.1. Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Early-Stage AMD
Intermediate AMD
Late-Stage AMD
6.2. Global Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ambulatory Surgical Centers
Ophthalmic Clinics
Hospitals
6.3. Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Other Route of Administration
6.4. Global Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Wet Macular Degeneration
Dry Macular Degeneration
6.5. Global Macular Degeneration Treatment Market, Sub-Segmentation Of Early-Stage AMD, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nutritional Supplements
Lifestyle Modification Treatments
6.6. Global Macular Degeneration Treatment Market, Sub-Segmentation Of Intermediate AMD, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anti-VEGF Injections
Photodynamic Therapy
6.7. Global Macular Degeneration Treatment Market, Sub-Segmentation Of Late-Stage AMD, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgical Treatments
Advanced Anti-VEGF Therapies
Gene Therapy Options
7. Macular Degeneration Treatment Market Regional And Country Analysis
7.1. Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Macular Degeneration Treatment Market
8.1. Asia-Pacific Macular Degeneration Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Macular Degeneration Treatment Market
9.1. China Macular Degeneration Treatment Market Overview
9.2. China Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Macular Degeneration Treatment Market
10.1. India Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Macular Degeneration Treatment Market
11.1. Japan Macular Degeneration Treatment Market Overview
11.2. Japan Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Macular Degeneration Treatment Market
12.1. Australia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Macular Degeneration Treatment Market
13.1. Indonesia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Macular Degeneration Treatment Market
14.1. South Korea Macular Degeneration Treatment Market Overview
14.2. South Korea Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Macular Degeneration Treatment Market
15.1. Western Europe Macular Degeneration Treatment Market Overview
15.2. Western Europe Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Macular Degeneration Treatment Market
16.1. UK Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Macular Degeneration Treatment Market
17.1. Germany Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Macular Degeneration Treatment Market
18.1. France Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Macular Degeneration Treatment Market
19.1. Italy Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Macular Degeneration Treatment Market
20.1. Spain Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Macular Degeneration Treatment Market
21.1. Eastern Europe Macular Degeneration Treatment Market Overview
21.2. Eastern Europe Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Macular Degeneration Treatment Market
22.1. Russia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Macular Degeneration Treatment Market
23.1. North America Macular Degeneration Treatment Market Overview
23.2. North America Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Macular Degeneration Treatment Market
24.1. USA Macular Degeneration Treatment Market Overview
24.2. USA Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Macular Degeneration Treatment Market
25.1. Canada Macular Degeneration Treatment Market Overview
25.2. Canada Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Macular Degeneration Treatment Market
26.1. South America Macular Degeneration Treatment Market Overview
26.2. South America Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Macular Degeneration Treatment Market
27.1. Brazil Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Macular Degeneration Treatment Market
28.1. Middle East Macular Degeneration Treatment Market Overview
28.2. Middle East Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Macular Degeneration Treatment Market
29.1. Africa Macular Degeneration Treatment Market Overview
29.2. Africa Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Macular Degeneration Treatment Market Competitive Landscape And Company Profiles
30.1. Macular Degeneration Treatment Market Competitive Landscape
30.2. Macular Degeneration Treatment Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Allergan Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Macular Degeneration Treatment Market Other Major And Innovative Companies
31.1. GlaxoSmithKline plc
31.2. Panoptica
31.3. Regeneron Pharmaceuticals Inc.
31.4. Bausch Health Companies Inc.
31.5. Santen Pharmaceuticals
31.6. Aerie Pharmaceuticals Inc.
31.7. BioXcel Therapeutics Inc.
31.8. Regenxbio Inc.
31.9. Spark Therapeutics Inc.
31.10. Alimera Sciences Inc.
31.11. Applied Genetic Technologies Corp (AGTC)
31.12. Cell Medica Ltd.
31.13. Ophthotech Corporation
31.14. Adverum Biotechnologies Inc.
31.15. Neurotech Pharmaceuticals Inc.
32. Global Macular Degeneration Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Macular Degeneration Treatment Market
34. Recent Developments In The Macular Degeneration Treatment Market
35. Macular Degeneration Treatment Market High Potential Countries, Segments and Strategies
35.1 Macular Degeneration Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Macular Degeneration Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Macular Degeneration Treatment Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings